Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats.

Maeda Y, Maeda R, Prineas JW, Ledeen RW.

J Neuropathol Exp Neurol. 1994 Nov;53(6):672-7.

PMID:
7964907
2.

Treatment of experimental allergic neuritis with prednisolone.

Feasby TE, Gilbert JJ, Hahn AF, Lovgren DS.

Can J Neurol Sci. 1987 Feb;14(1):46-9.

PMID:
3493057
4.

Gangliosides improve the outcome of experimental allergic neuritis (EAN).

Oderfeld-Nowak B, Brosnan C, Cervone A, Oderfeld J, Ledeen RW.

Acta Neurobiol Exp (Wars). 1990;50(4-5):495-504.

5.

Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.

Zou LP, Deretzi G, Pelidou SH, Levi M, Wahren B, Quiding C, van der Meide P, Zhu J.

Neuropharmacology. 2000 Jan 4;39(2):324-33.

PMID:
10670428
6.

High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat.

Watts PM, Taylor WA, Hughes RA.

Exp Neurol. 1989 Jan;103(1):101-4.

PMID:
2463936
7.

Suppression of experimental autoimmune neuritis by leflunomide.

Korn T, Toyka K, Hartung HP, Jung S.

Brain. 2001 Sep;124(Pt 9):1791-802.

PMID:
11522581
8.

Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease.

Stevens A, Schabet M, Wiethölter H, Schott K.

J Neuroimmunol. 1990 Jul;28(2):141-51.

PMID:
2362015
9.

The use of protease inhibitors in experimental allergic neuritis.

Schabet M, Whitaker JN, Schott K, Stevens A, Zürn A, Bühler R, Wiethölter H.

J Neuroimmunol. 1991 Mar;31(3):265-72.

PMID:
1825313
10.

Gangliosides offer partial protection in experimental allergic neuritis.

Ledeen RW, Oderfeld-Nowak B, Brosnan CF, Cervone A.

Ann Neurol. 1990;27 Suppl:S69-74.

PMID:
2363571
11.

Protection against experimental allergic neuritis with silica quartz dust.

Tansey FA, Brosnan CF.

J Neuroimmunol. 1982 Nov;3(3):169-79.

PMID:
6292260
12.

The role of myelin P2 protein in the production of experimental allergic neuritis.

Rostami A, Brown MJ, Lisak RP, Sumner AJ, Zweiman B, Pleasure DE.

Ann Neurol. 1984 Dec;16(6):680-5.

PMID:
6084458
13.

Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.

Gaupp S, Hartung HP, Toyka K, Jung S.

J Neuroimmunol. 1997 Nov;79(2):129-37.

PMID:
9394785
14.

Oral administration of type I interferon modulates the course of experimental allergic neuritis.

Vriesendorp FJ, Flynn RE, Khan M, Pappolla MA, Brod SA.

Autoimmunity. 1996;24(3):157-65.

PMID:
9020408
15.
16.

Treatment of rats with experimental allergic neuritis using high dose immunoglobulin.

Jia J, Jia J, Pollock M.

Chin Med J (Engl). 2000 Dec;113(12):1096-9.

PMID:
11776144
17.

Clomipramine and imipramine suppress clinical signs and T and B cell response to myelin proteins in experimental autoimmune neuritis in Lewis rats.

Zhu J, Bengtsson BO, Mix E, Ekerling L, Thorell LH, Olsson T, Link H.

J Autoimmun. 1998 Aug;11(4):319-27.

PMID:
9776709
18.

Complement depletion suppresses Lewis rat experimental allergic neuritis.

Feasby TE, Gilbert JJ, Hahn AF, Neilson M.

Brain Res. 1987 Sep 1;419(1-2):97-103.

PMID:
3499953
19.

Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.

Archelos JJ, Mäurer M, Jung S, Miyasaka M, Tamatani T, Toyka KV, Hartung HP.

Lab Invest. 1994 May;70(5):667-75.

PMID:
8196363
20.

The effect of suppression of macrophage activity on the development of experimental allergic neuritis.

Craggs RI, King RH, Thomas PK.

Acta Neuropathol. 1984;62(4):316-23.

PMID:
6328830

Supplemental Content

Support Center